Virtus ETF Advisers LLC Biomea Fusion, Inc. Transaction History

Virtus ETF Advisers LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$13.92 - $19.5 $5,888 - $8,248	-423 Reduced 6.42%	6,166 $92,000
Q4 2023 Feb 15, 2024	BUY	$8.37 - $19.8 $33,865 - $80,110	4,046 Added 159.1%	6,589 $95,000
Q3 2023 Nov 07, 2023	SELL	$13.44 - $23.02 $3,386 - $5,801	-252 Reduced 9.02%	2,543 $34,000
Q2 2023 Aug 14, 2023	BUY	$21.66 - $41.8 $60,539 - $116,830	2,795 New	2,795 $61,000

104

17.8M

1.68M

410K

Ticker BMEA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,290,600
Market Cap $189M
Description
Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.